Rua Bioscience (NZSE:RUA) FCF Margin %: -113.94% (As of Dec. 2025)


What is Rua Bioscience FCF Margin %?

Rua Bioscience NZSE:RUA FCF Margin % is -113.94% as of Dec. 2025. The stock has 4 warning signs investors should review. Among 958 Drug Manufacturers companies, Rua Bioscience ranks worse than 92.28% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Rua Bioscience's Free Cash Flow for the six months ended in Dec. 2025 was NZ$-1.52 Mil. Rua Bioscience's Revenue for the six months ended in Dec. 2025 was NZ$1.33 Mil. Therefore, Rua Bioscience's FCF Margin % for the quarter that ended in Dec. 2025 was -113.94%.

As of today, Rua Bioscience's current FCF Yield % is -24.26%.

The historical rank and industry rank for Rua Bioscience's FCF Margin % or its related term are showing as below:

NZSE:RUA' s FCF Margin % Range Over the Past 10 Years
Min: -30187.5   Med: -3009.83   Max: -106.74
Current: -106.74

During the past 5 years, the highest FCF Margin % of Rua Bioscience was -106.74%. The lowest was -30187.50%. And the median was -3009.83%.

NZSE:RUA's FCF Margin % is ranked worse than
92.28% of 958 companies
in the Drug Manufacturers industry
Industry Median: 2.445 vs NZSE:RUA: -106.74

Rua Bioscience FCF Margin % Related Terms

Rua Bioscience FCF Margin % Historical Data

* Premium members only.

The historical data trend for Rua Bioscience's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rua Bioscience FCF Margin % Chart

Rua Bioscience Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
FCF Margin %
0.00 -30,187.50 -1,674.30 -4,345.35 -180.15

Rua Bioscience Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -12,547.06 -2,326.09 -279.97 -94.98 -113.94

NZSE:RUA vs ZTS, UTHR, VTRS: FCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Rua Bioscience's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rua Bioscience FCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Rua Bioscience's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Rua Bioscience's FCF Margin % falls into.


Rua Bioscience FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Rua Bioscience's FCF Margin for the fiscal year that ended in Jun. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Jun. 2025 )/Revenue (A: Jun. 2025 )
=-2.722/1.511
=-180.15 %

Rua Bioscience's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-1.52/1.334
=-113.94 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -113.94% mean?
Rua Bioscience (NZSE:RUA) has a FCF Margin % of -113.94% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Rua Bioscience and its competitors. According to the industry distribution chart, Rua Bioscience ranks #884 out of 958 companies in the Drug Manufacturers industry, placing it in the top 92.3%.
Is Rua Bioscience's FCF Margin % too high?
Rua Bioscience's current FCF Margin % is -113.94%. Based on the distribution chart, Rua Bioscience ranks #884 out of 958 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Rua Bioscience's FCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Rua Bioscience ranks #884 out of 958 companies for FCF Margin %. This places Rua Bioscience in the lower half of its industry. The industry median FCF Margin % is 2.45. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.45, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Rua Bioscience and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rua Bioscience's current FCF Margin % is -113.94%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rua Bioscience stock overvalued right now?
Rua Bioscience (NZSE:RUA) has a current FCF Margin % of -113.94%. The current FCF Margin % is -113.94%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Rua Bioscience (NZSE:RUA), the current FCF Margin % is -113.94% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Rua Bioscience Business Description

Address 704 Te Araroa Road, RD3, Ruatoria, NZL, 4083
Rua Bioscience Ltd is a pharmaceutical company engaged in the production of cannabinoid medicines. The company caters to both domestic and international customers. It operates in one segment, being research and development and the sale of pharmaceutical products in Australia, Germany, and New Zealand.